rs536294863
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 3P and 13B. PM1PP2BP4_StrongBP6_Very_StrongBS2_Supporting
The NM_000371.4(TTR):c.437A>G(p.Lys146Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,614,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. K146K) has been classified as Likely benign.
Frequency
Consequence
NM_000371.4 missense
Scores
Clinical Significance
Conservation
Publications
- amyloidosis, hereditary systemic 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- familial amyloid neuropathyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary ATTR amyloidosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- heart conduction diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- ATTRV122I amyloidosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTR | ENST00000237014.8 | c.437A>G | p.Lys146Arg | missense_variant | Exon 4 of 4 | 1 | NM_000371.4 | ENSP00000237014.4 | ||
TTR | ENST00000649620.1 | c.437A>G | p.Lys146Arg | missense_variant | Exon 6 of 6 | ENSP00000497927.1 | ||||
TTR | ENST00000610404.5 | c.341A>G | p.Lys114Arg | missense_variant | Exon 4 of 4 | 5 | ENSP00000477599.2 | |||
ENSG00000294516 | ENST00000724044.1 | n.286-2973T>C | intron_variant | Intron 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152168Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000350 AC: 88AN: 251400 AF XY: 0.000213 show subpopulations
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727236 show subpopulations
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74460 show subpopulations
ClinVar
Submissions by phenotype
not provided Benign:2
Variant summary: The TTR c.437A>G (p.Lys146Arg) variant involves the alteration of a non-conserved nucleotide. 5/5 in silico tools predict a benign outcome for this variant. This variant was found in 48/121306 control chromosomes, predominantly observed in the Latino subpopulation at a frequency of 0.004151 (48/11564). This frequency is about 133 times the estimated maximal expected allele frequency of a pathogenic TTR variant (0.0000313), suggesting this is likely a benign polymorphism found primarily in the populations of Latino origin. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely benign. Taken together, this variant is classified as benign. -
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Amyloidosis, hereditary systemic 1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at